Cynosure Management, LLC Pfizer Inc Transaction History

Cynosure Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $242,676 - $294,402	-8,057 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $38,409 - $54,879	-1,421 Reduced 14.99%	8,057 $263,000
Q3 2019 Nov 08, 2019	SELL	$32.49 - $42.13 $108,938 - $141,261	-3,353 Reduced 26.13%	9,478 $341,000
Q2 2019 Aug 06, 2019	BUY	$36.98 - $41.52 $474,490 - $532,743	12,831 New	12,831 $556,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Cynosure Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cynosure Management, LLC with notifications on news.